Company Filing History:
Years Active: 2009
Title: Keren Ailon: Innovator in Trait Anxiety Assessment
Introduction
Keren Ailon is a notable inventor based in Givat Yearim, Israel. He has made significant contributions to the field of psychology and genetics through his innovative research. His work focuses on methods for assessing anxiety levels, which can have profound implications for mental health treatment.
Latest Patents
Keren Ailon holds a patent for a "Method for assessing trait anxiety by determining cholinergic status." This invention provides methods and kits for evaluating levels of trait or state anxiety in a subject. The assessment is achieved by comparing genotypes and/or expression patterns at the ACHE, PON1, and/or BChE genes to those in a reference population. Additionally, it correlates AChE levels and activity to those of PON.
Career Highlights
Ailon is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding of anxiety disorders and their genetic underpinnings. He has successfully developed methodologies that can aid in the diagnosis and treatment of anxiety-related conditions.
Collaborations
Keren Ailon has collaborated with esteemed colleagues, including Hermona Soreq and Ella Sklan. These partnerships have enriched his research and contributed to the development of innovative solutions in the field of anxiety assessment.
Conclusion
Keren Ailon's contributions to the assessment of trait anxiety through genetic analysis represent a significant advancement in mental health research. His innovative methods have the potential to improve diagnostic accuracy and treatment options for individuals suffering from anxiety disorders.